NASDAQ: BLTE
Belite Bio Inc Stock Ownership - Who owns Belite Bio?

Insider buying vs selling

Have Belite Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BLTE insiders and whales buy or sell their stock.

BLTE Shareholders

What type of owners hold Belite Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Alyeska Investment Group LP0.26%83,623$4.94MInstitution
State Street Corp0.06%20,098$1.19MInstitution
Geode Capital Management LLC0.04%12,753$752.94kInstitution
Jpmorgan Chase Co0.03%8,162$481.88kInstitution
Citadel Advisors LLC0.02%5,689$335.88kInstitution
Bank Of America Corp0.02%5,224$308.42kInstitution
Hrt Financial LP0.01%4,117$243.07kInstitution
Ameriprise Financial Inc0.01%3,075$181.55kInstitution
Virtus Investment Advisers LLC0.01%2,589$152.85kInstitution
Gamma Investing LLC0.01%1,849$109.16kInstitution

1 of 2

BLTE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BLTE0.47%0.00%
IRON56.36%43.64%Net SellingNet Selling
IDYA92.55%7.45%Net Buying
GLPG47.15%0.00%
HRMY70.06%29.94%Net SellingNet Selling

Belite Bio Stock Ownership FAQ

Who owns Belite Bio?

Belite Bio (NASDAQ: BLTE) is owned by 0.47% institutional shareholders, 0.00% Belite Bio insiders, and 99.53% retail investors. Alyeska Investment Group LP is the largest individual Belite Bio shareholder, owning 83,623.00 shares representing 0.26% of the company. Alyeska Investment Group LP's Belite Bio shares are currently valued at $4.83M.

If you're new to stock investing, here's how to buy Belite Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.